Clinical Trial Update: Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of dasatinib for Philadelphia-positive acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Lymphoblastic Acute Philadelphia-positive

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Grupo Espanol de trasplantes hematopoyeticos y terapia celular | Conditions: Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Phase 2 | Status: COMPLETED